Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Antibiotic-resistant 'superbug' gene found in UK dog
Researchers are calling for improved surveillance of ‘last resort’ antimicrobials.
‘Surprise’ finding highlights need for routine surveillance

Researchers are calling for improved surveillance of ‘last resort’ antimicrobials in companion animals after a drug-resistant ‘superbug’ gene was discovered in a UK dog for the first time.

Scientists made the discovery in a springer spaniel after isolating Escherichia coli (E. Coli) from a wound. The isolate was found to harbour a gene resistant to carbapenems - a class of antibiotics used to treat-life-threatening infections - along with genes resistant to other commonly-used antibiotics.

The study is published in the Journal of Antimicrobial Chemotherapy.

Dr Dorina Timofte, who oversaw the study at the University of Liverpool’s Institute of Veterinary Science, said: “Worldwide there are very few reports of carbapenem-resistant isolates in pets and although the prevalence identified in this study was low (0.5 per cent), it was still surprising.”

“Carbapenems are not authorised for use in EU or UK companion animals, but these findings are worrying due to the close contact between household pets and people which may allow bacteria to transfer between the species.”

She continued: “Although epidemiological data was not available for us to determine the origin of this carbapenem-resistant isolate, the similarity of its genetic background with that of human isolates carrying the same resistance genes here in the UK suggests that it may indeed be of human origin.”

“Larger, systematic and prospective studies are now needed to identify the occurrence of carbapenem-resistance in companion animals, which we hope to address in future projects.”

Scientists say the finding highlights the need for routine laboratory detection of carbapenem resistance in companion animals and improved antimicrobial stewardship in veterinary practice.

In recent years, various multi-drug resistant pathogens - including MRSA - have been associated with illness and carriage in pets. But while surveillance of resistance to commonly used antibiotics has grown, there is limited surveillance of ‘last resort’ antimicrobials like carbapenems.

Dr Timofte continued: “Veterinary diagnostic laboratories play a major role in surveillance of AMR, monitoring trends of resistance and detecting new emerging patterns of resistance, yet at present screening for resistance to last resort antimicrobials is voluntary.”

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.